# Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units

> **NCT04829552** · — · COMPLETED · sponsor: **Corewell Health East** · enrollment: 704 (actual)

## Conditions studied

- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04829552
- **Lead sponsor:** Corewell Health East
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-10
- **Primary completion:** 2020-04-15
- **Final completion:** 2020-04-15
- **Target enrollment:** 704 (ACTUAL)
- **Last updated:** 2021-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04829552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04829552, "Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04829552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*